Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW873140 (Aplaviroc) in Treatment-Experienced HIV-Infected Subjects
NCT00197145Phase 3Terminated
- Sponsor
- ViiV Healthcare
- Start
- Jul 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of aplaviroc in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Started Jul 2005; status: terminated.
02
Drugs
aplaviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00197145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00197145.